Description
Cagrilintide is a long-acting synthetic analog of amylin, the peptide hormone co-secreted with insulin from pancreatic beta cells. With acylation modifications that extend its half-life through albumin binding, Cagrilintide has been studied as a research compound in amylin receptor pharmacology, satiety pathway research, and metabolic regulation in laboratory models.
Cagrilintide is frequently studied alongside GLP-1 analogs in comparative incretin/amylin research, making it a useful tool for understanding amylin-receptor pharmacology.
Research areas studied
- Amylin receptor (AMY1, AMY2, AMY3) pharmacology
- Satiety and food intake research in laboratory models
- Comparative incretin/amylin pharmacology
Quality assurance
- HPLC verified at 99%+ purity
- Certificate of Analysis (COA) available upon request
- Lyophilized in a research-grade facility under controlled conditions
For research purposes only. Not for human consumption, diagnostic, or therapeutic use.